![]() |
优势北京Peprotech 210-13 Recombinant Murine IL-13细胞因子价格
品名:Recombinant Murine IL-13
货号:210-13
规格:2UG/10UG
品牌:Peprotech
北京杰辉博高生物技术有限公司在广大科研用户的帮助和支持下,经过多年不懈的努力,已成为国内生命科学试剂的国际运营商之一,代理许多国际先进水平的高科技产品,包括分子生物学、细胞生物学、免疫学、诊断,仪器仪表等多个研究及应用领域。。
Catalog Number:
210-13
Synonyms:
NC300 (Human) P600 (Murine)
Description:
IL-13 is an immunoregulatory cytokine produced primarily by activated Th2 cells, and also by mast cells and NK cells. Targeted deletion of IL-13 in mice resulted in impaired Th2 cell development and indicated an important role for IL-13 in the expulsion of gastrointestinal parasites. IL-13 exerts anti-inflammatory effects on monocytes and macrophages and it inhibits the expression of inflammatory cytokines such as IL-1β, TNF-α, IL-6 and IL-8. IL-13 has also been shown to enhance B cell proliferation and to induce isotype switching resulting in increased production of IgE. Blocking of IL-13 activity inhibits the pathophysiology of asthma. Human and murine IL-13 is cross-species reactive. Recombinant murine IL-13 is a 12.3 kDa protein consisting of 111 amino acid residues.
AA Sequence:
MPVPRSVSLP LTLKELIEEL SNITQDQTPL CNGSMVWSVD LAAGGFCVAL DSLTNISNCN AIYRTQRILH GLCNRKAPTT VSSLPDTKIE VAHFITKLLS YTKQLFRHGP F
Source:
E.coli
Purity:
Greater than 98% by SDS-PAGE gel and HPLC analyses.
Biological Activity:
The ED 50 as determined by the dose-dependent proliferation of TF-1 cells was < 4.0 ng/ml, corresponding to a specific activity of > 2.5 x 10 5 units/mg.
Cross Reactivity:
Human, Mouse
450-01 | Recombinant Human beta-NGF | Peprotech | 5ug/20ug/ | 支 |
450-34 | Recombinant Murine β-NGF | Peprotech | 5ug/20ug/ | 支 |
120-02 | Recombinant Human BMP-2 | Peprotech | 2ug/10ug/ | 支 |
315-09 | Recombinant Murine EGF | Peprotech | 100ug/500ug/ | 支 |
100-15 | Recombinant Human EGF | Peprotech | 100ug/500ug/ | 支 |
100-17A | Recombinant Human FGF-acidic | Peprotech | 50ug/1mg | 支 |
100-17A | Recombinant Human FGF-acidic | Peprotech | 10ug/50ug/ | 支 |
450-33A | Recombinant Murine FGF-acidic | Peprotech | 10ug/50ug/ | 支 |
100-18B | Recombinant Human FGF-basic | Peprotech | 50ug/1mg | 支 |
100-18B | Recombinant Human FGF-basic | Peprotech | 10ug/50ug/ | 支 |
450-33 | Recombinant Murine FGF-basic | Peprotech | 10ug/50ug/ | 支 |
250-05 | Recombinant Murine G-CSF | Peprotech | 2ug/10ug/ | 支 |
300-23 | Recombinant Human G-CSF | Peprotech | 2ug/10ug/ | 支 |
300-03 | Recombinant Human GM-CSF | Peprotech | 10ug/1mg/ | 支 |
300-03 | Recombinant Human GM-CSF | Peprotech | 2ug/10ug/ | 支 |
315-03 | Recombinant Murine GM-CSF | Peprotech | 10ug/1mg/ | 支 |
315-03 | Recombinant Murine GM-CSF | Peprotech | 2ug/10ug/ | 支 |
100-39 | Recombinant Human HGF | Peprotech | 2ug/10ug/ | 支 |
300-02 | Recombinant Human IFN-r | Peprotech | 20ug/100ug/ | 支 |
315-05 | Recombinant Murine IFN-r | Peprotech | 20ug/100ug/ | 支 |
100-11 | Recombinant Human IGF-1 | Peprotech | 100ug/1mg | 支 |
100-11 | Recombinant Human IGF-1 | Peprotech | 20ug/100ug/ | 支 |
250-19 | Recombinant Murine IGF-1 | Peprotech | 10ug/50ug/ | 支 |
100-19 | Recombinant Human KGF | Peprotech | 10ug/1mg/ | 支 |
100-19 | Recombinant Human KGF(FGF-7) | Peprotech | 2ug/10ug/ | 支 |
200-01A | Recombinant Human IL-1α | Peprotech | 5ug/25ug/ | 支 |
211-11A | Recombinant Murine IL-1a | Peprotech | 2ug/10ug/ | 支 |
200-01B | Recombinant Human IL-1β | Peprotech | 2ug/10ug/ | 支 |
211-11B | Recombinant Murine IL-1β | Peprotech | 2ug/10ug/ | 支 |
200-02 | Recombinant Human IL-2 | Peprotech | 50ug/1mg | 支 |
200-02 | Recombinant Human IL-2 | Peprotech | 10ug/50ug/ | 支 |
212-12 | Recombinant Murine IL-2 | Peprotech | 5ug/20ug/ | 支 |
200-03 | Recombinant Human IL-3 | Peprotech | 10ug/1mg/ | 支 |
200-03 | Recombinant Human IL-3 | Peprotech | 5ug/25ug/ | 支 |
213-13 | Recombinant Murine IL-3 | Peprotech | 2ug/10ug/ | 支 |
200-04 | Recombinant Human IL-4 | Peprotech | 10ug/1mg/ | 支 |
200-04 | Recombinant Human IL-4 | Peprotech | 2ug/10ug/ | 支 |
214-14 | Recombinant Murine IL-4 | Peprotech | 2ug/10ug/ | 支 |
216-16 | Recombinant Murine IL-6 | Peprotech | 5ug/20ug/ | 支 |
200-06 | Recombinant Human IL-6 | Peprotech | 5ug/20ug/ | 支 |
200-10 | Recombinant Human IL-10 | Peprotech | 2ug/10ug/ | 支 |
210-10 | Recombinant Murine IL-10 | Peprotech | 2ug/10ug/ | 支 |
200-11 | Recombinant Human IL-11 | Peprotech | 2ug/10ug/ | 支 |
220-11 | Recombinant Murine IL-11 | Peprotech | 2ug/10ug/ | 支 |
200-12 | Recombinant Human IL-12 | Peprotech | 2ug/10ug/ | 支 |
210-12 | Recombinant Murine IL-12 | Peprotech | 2ug/10ug/ | 支 |
200-13 | Recombinant Human IL-13 | Peprotech | 2ug/10ug/ | 支 |
210-13 | Recombinant Murine IL-13 | Peprotech | 2ug/10ug/ | 支 |
200-15 | Recombinant Human IL-15 | Peprotech | 2ug/10ug/ | 支 |
210-15 | Recombinant Murine IL-15 | Peprotech | 2ug/10ug/ | 支 |
200-17 | Recombinant Human IL-17 | Peprotech | 2ug/10ug/ | 支 |
210-17 | Recombinant Murine IL-17 | Peprotech | 2ug/10ug/ | 支 |
300-01A | Recombinant Human TNF-a | Peprotech | 10ug/50ug/ | 支 |
315-01a | Recombinant Murine TNF-a | Peprotech | 5ug/20ug/ | 支 |
100-20 | Recombinant Human VEGF165 | Peprotech | 10ug/1mg/ | 支 |
100-20 | Recombinant Human VEGF165 | Peprotech | 2ug/10ug/ | 支 |
450-32 | Recombinant Murine VEGF | Peprotech | 2ug/10ug/ | 支 |
CYT-201 | Recombinant Human EPO | Prospec | 5ug/50ug | 支 |
Recombinant Human HGH | Prospec | 支 | ||
CYT-204 | Recombinant Human IFN-α2a | Prospec | 20ug/100ug/ | 支 |
CYT-205 | Recombinant Human IFN-α2b | Prospec | 支 |